Loading News...
Volver al Panel

Becton, Dickinson and Company (BDX)

Valores intradiarios en tiempo real

Resumen del Mercado

From:
To:
BDX Intraday
No data available
SímboloBDX
Fecha de SalidaFeb 21, 1973
CEOMr. Thomas E. Polen Jr.
Empleados a Tiempo Completo72k
SectorHealthcare
IndustriaMedical Instruments & Supplies
PaísUnited States
BolsaNYSE
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Rendimiento
PeríodoRentabilidad %Cambio de Valor
1 Día
-0.77%
-1.54 US$
5 Días
+3.72%
+7.13 US$
1 Mes
+8.96%
+16.36 US$
6 Meses
+30.72%
+46.74 US$

Analizando el Mercado con IA

Evaluando los últimos 30 días de historial y métricas fundamentales de BDX...

Estadísticas Clave
Cap. de Mercado
54.18B
Relación P/E
46.26
Rend. de Div.
2.11%
Máx. 52 Semanas
$200.47
Mín. 52 Semanas
$127.59

Consenso de Analistas

CONSENSOCompra
ALCISTA850.0%
NEUTRAL743.8%
BAJISTA16.3%

Objetivos de Precios de Analistas a 52 Semanas

Objetivo Mín.
$165.00
Objetivo Máx.
$225.00
Actual$198.88
Objetivo Prom.$195.57

Recomendaciones de Analistas

Precio Objetivo:$195.57($165.00 - $225.00)
FirmaCalificaciónPrecio ObjetivoPotencial de AlzaFecha
BarclaysUnderweight$165.00-17.04%7/10/2026
B of A SecuritiesNeutral$200.00+0.56%31/8/2026
RBC CapitalSector Perform$190.00-4.47%13/8/2026
CitigroupBuy$204.00+2.57%7/8/2026
RBC CapitalSector Perform$180.00-9.49%7/8/2026
Piper SandlerNeutral$175.00-12.01%7/8/2026
Wells FargoEqual-Weight$170.00-14.52%7/8/2026
TD CowenHold$182.00-8.49%5/8/2026
UBSBuy$190.00-4.47%28/7/2026
Evercore ISI GroupOutperform$180.00-9.49%6/7/2026
Pensamientos de la Comunidad

Comparta su análisis y sentimiento sobre BDX

Únase a la comunidad para compartir su análisis